StarBright Dyes are conjugated to a growing range of antibodies and are compatible with most flow cytometers and experimental protocols.

ZEISS today introduces the Advanced Reconstruction Toolbox for its industry-leading ZEISS Xradia 3D X-ray microscope and computed tomography systems. With the Toolbox, two modules are announced: an upgraded ZEISS OptiRecon for iterative reconstruction, and ZEISS DeepRecon, microscopy’s first commercially available deep learning reconstruction technology.

The white paper discusses what LIMS validation is and the steps involved, the responsibilities of the customer and supplier, how GAMP5 affects LIMS validation, and the deliverables you can expect from a LIMS validation project.

Life science and data technology innovator, Aigenpulse, is launching its CytoML Experiment Suite – an automated, end-to-end, machine learning solution specifically aimed at streamlining and automating cytometry analysis at scale and replacing manual gating processes.

The CEOs of nine biopharmaceutical companies announced a historic pledge, outlining a united commitment to uphold the integrity of the scientific process as they work towards potential global regulatory filings and approvals of the first COVID-19 vaccines.

CN Bio’s Liver-on-Chip technology to define underlying disease mechanisms and screen therapeutic targets.

The BioScaffolder Prime from Analytik is a new affordable high-performance 3D bioprinter that delivers precision engineering in an advanced, customisable platform.

BioChromato Inc. has made a major investment to expand sales, marketing and customer support activities in international markets, most notably Europe and North America.

A multi-site, Phase 3 clinical trial evaluating an investigational COVID-19 vaccine known as AZD1222 has begun.

Avacta has entered into an agreement with Abingdon Health for the manufacture of Avacta’s saliva-based rapid SARS-CoV-2 antigen test as part of its ongoing expansion of manufacturing capacity.